Vaccines, Blood & Biologics
-
?
-
Variances for Collection of Blood and Blood Products from Patients with Hemochromatosis
The Center for Biologics Evaluation and Research maintains a list of establishments granted approval for a variance to 21CFR640.3(d) and 21CFR640.3(f) in order to collect blood and blood products from patients with hemochromatosis.
-
Key Resources
List of Establishments Granted Approval for a Variance to 21CFR640.3(d) and 21CFR640.3(f) Variances for Collection of Blood and Blood Products from Patients with Hemochromatosis, Information as of May 28, 2010
-
-
Related Information
-
Contact FDA
(800) 835-4709
(301) 827-1800
Consumer Affairs Branch (CBER)
Division of Communication and Consumer Affairs
Office of Communication, Outreach and Development
Food and Drug Administration
1401 Rockville Pike
Suite 200N/HFM-47
Rockville, MD 20852-1448
-
-